chartexchange

QTTB
Q32 Bio Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
8.52USD-1.275%(-0.11)261,851
Pre-marketNov 19, 2026 8:35:30 AM EST
8.50USD-0.352%(-0.03)
After-hoursNov 18, 2026 4:00:30 PM EST
8.53USD+0.117%(+0.01)
Loading…
Loading…
255.10M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bedford, Massachusetts, USA
Previous Close
$8.63
Beta
-0.03
52-Week High
$23.57 2026-07-14
52-Week Low
$1.91 2025-11-20
SMA 50
$9.03
SMA 200
$9.56
Avg. Vol 10D
359,951
Avg. Vol 30D
467,142
Avg. Vol 90D
739,815
Relative Vol
0.56
13.67M
0.7400%
335
Mar 26, 2024 · 1-for-18 (reverse)
QTTB Profile

homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.

QTTB Performance
PeriodPriceDateChangeBeta
1W8.822026-11-12-3.35%1.819
1M7.792026-10-19+9.44%0.668
3M15.842026-08-19-46.18%0.594
6M6.072026-05-19+40.45%-0.195
1Y2.122025-11-19+302.12%-0.029
2Y29.092024-11-19-70.69%—
QTTB Stock Summary

Q32 Bio Inc. Common Stock (NASDAQ:QTTB) stock price today is $8.53, and today's volume is 261,851. QTTB is down 1.217% today. The 30 day average volume is 467,142. QTTB market cap is $255.10M with 29.92M shares outstanding.